Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025

Description

Neonatal respiratory distress syndrome (NRDS) treatment focuses on managing premature infants who experience breathing difficulties due to inadequate surfactant production. This treatment typically includes the administration of exogenous surfactant therapy, respiratory support through mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.

The primary treatments for neonatal respiratory distress syndrome are oxygen therapy and surfactant therapy. Oxygen therapy involves supplying oxygen to patients who struggle to get enough oxygen through normal breathing. It can be delivered via parenteral routes, inhalation, or other methods, and is used in hospitals, sub-acute facilities, home care settings, and retail pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neonatal respiratory distress syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides neonatal respiratory distress syndrome treatment market statistics, including neonatal respiratory distress syndrome treatment industry global market size, regional shares, competitors with a neonatal respiratory distress syndrome treatment market share, detailed neonatal respiratory distress syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal respiratory distress syndrome treatment industry. This neonatal respiratory distress syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal respiratory distress syndrome treatment market size has grown strongly in recent years. It will grow from $0.96 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing permeability and fluid accumulation within the alveoli, increasing alveolar-capillary permeability, increase in utilization of mechanical ventilation, increasing awareness among healthcare providers and parents about the importance of neonatal care, increasing healthcare investments.

The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing preference for accessories and consumables, rising NICU admissions, increasing demand for personalized medicine, increasing premature birth, increasing research and development activities. Major trends in the forecast period include automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI), technological advancement in neonatal care, surfactant therapy innovation, advanced ventilator technologies.

The forecast of 7.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. Neonatal intensive care units by driving up the cost of surfactant replacements and high-frequency ventilators sourced from Ireland and France, exacerbating respiratory crisis management and increasing critical care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of premature births is expected to drive the expansion of the neonatal respiratory distress syndrome (NRDS) treatment market. Premature birth, or preterm birth, occurs when a baby is born before 37 weeks of pregnancy, with those born before 32 weeks facing the greatest health risks, as a typical pregnancy lasts about 40 weeks. The rise in premature births is attributed to factors such as advancing maternal age, multiple pregnancies, medical conditions, lifestyle choices, fertility treatments, infections, and environmental influences. Neonatal respiratory distress syndrome is commonly seen in premature infants due to their underdeveloped lungs and insufficient surfactant production. Treatment for NRDS helps improve lung function, stabilize breathing, and lower the risk of respiratory failure in preterm babies. For example, Tommy's, a UK-based charity, reported in December 2022 that the percentage of premature live births in England and Wales increased to 7.9% in 2022 from 7.5% in 2021, marking a second consecutive year of rising premature births, with over 53,000 babies born prematurely that year. As a result, the growing incidence of premature births is fueling the growth of the NRDS treatment market.

Leading companies in the neonatal respiratory distress syndrome treatment market are focusing on the development of advanced technologies such as nitric oxide generators to improve oxygenation, reduce respiratory complications, and provide non-invasive treatment options for neonates with hypoxic respiratory failure. A nitric oxide generator is a device that produces and administers nitric oxide gas, which is used to treat respiratory issues by enhancing oxygenation and reducing pulmonary hypertension, especially in neonates and critically ill patients. For example, in June 2022, Beyond Air Inc., a US-based medical device and biopharmaceutical company, received FDA approval for its LungFit PH. This innovative nitric oxide generator is designed to treat term and near-term neonates with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device utilizes Beyond Air's patented Ionizer technology to generate nitric oxide on demand from ambient air, providing a continuous supply without concerns about dosage or flow. It also uses a low-power compressor to ionize nitrogen and oxygen, minimizing the production of nitrogen dioxide (NO2), which is then safely filtered out using a smart filter.

In January 2024, Chiesi Group, an Italy-based biopharmaceutical company, entered into a partnership with Oak Hill Bio to advance neonatal therapies. This collaboration aims to develop and commercialize OHB-607, an innovative treatment designed to prevent severe bronchopulmonary dysplasia (BPD) and its long-term respiratory complications in preterm infants, especially those born before 28 weeks gestational age with low IGF-1 levels. Oak Hill Bio is a UK-based company focused on developing treatments for neonatal and rare diseases.

Major players in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Dragerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., and Lyomark Pharma GmbH.

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal respiratory distress syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neonatal respiratory distress syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neonatal respiratory distress syndrome treatment market consists of revenues earned by entities by providing services such as surfactant administration services, neonatal respiratory care consulting, telemedicine, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal respiratory distress syndrome treatment market also includes sales of mechanical ventilators, continuous positive airway pressure (CPAP) machines, high-frequency ventilators, and neonatal incubators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neonatal respiratory distress syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal respiratory distress syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal respiratory distress syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy: Oxygen Therapy; Surfactant Therapy
2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies
Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy
Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Abbott Laboratories; Medtronic Plc; Medline Industries; Becton Dickinson; Stryker Corporation; GE Healthcare; Koninklijke Philips NV; ResMed Inc.; Dragerwerk AG & Co. KGaA; Chiesi Farmaceutici; ICU Medical Inc.; Fisher & Paykel Healthcare; Vyaire Medical; Laerdal Medical; Hamilton Medical; Inspiration Healthcare; Ventec Life Systems; Neotech Products; Aerogen Pharma Corp.; Windtree Therapeutics Inc.; Discovery Laboratories Inc.; Lyomark Pharma GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33829u

1. Executive Summary

2. Neonatal Respiratory Distress Syndrome Treatment Market Characteristics

3. Neonatal Respiratory Distress Syndrome Treatment Market Trends And Strategies

4. Neonatal Respiratory Distress Syndrome Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neonatal Respiratory Distress Syndrome Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Neonatal Respiratory Distress Syndrome Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate Analysis
5.4. Global Neonatal Respiratory Distress Syndrome Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neonatal Respiratory Distress Syndrome Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neonatal Respiratory Distress Syndrome Treatment Total Addressable Market (TAM)

6. Neonatal Respiratory Distress Syndrome Treatment Market Segmentation

6.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oxygen Therapy
Surfactant Therapy
6.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Inhalation
Other Routes Of Administration
6.3. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Sub-Acute Facilities
Home Care
Retail Pharmacies
6.4. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Oxygen Therapy
High-Flow Nasal Cannula (HFNC) Oxygen Therapy
Continuous Positive Airway Pressure (CPAP) Oxygen Therapy
Invasive Mechanical Ventilation With Oxygen Therapy
6.5. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Surfactant Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Surfactants
Synthetic Surfactants
Combined Surfactant Therapy (Natural + Synthetic)
Prophylactic Surfactant Therapy
Rescue Surfactant Therapy

7. Neonatal Respiratory Distress Syndrome Treatment Market Regional And Country Analysis

7.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market

8.1. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neonatal Respiratory Distress Syndrome Treatment Market

9.1. China Neonatal Respiratory Distress Syndrome Treatment Market Overview
9.2. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neonatal Respiratory Distress Syndrome Treatment Market

10.1. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neonatal Respiratory Distress Syndrome Treatment Market

11.1. Japan Neonatal Respiratory Distress Syndrome Treatment Market Overview
11.2. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neonatal Respiratory Distress Syndrome Treatment Market

12.1. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market

13.1. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neonatal Respiratory Distress Syndrome Treatment Market

14.1. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Overview
14.2. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market

15.1. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
15.2. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neonatal Respiratory Distress Syndrome Treatment Market

16.1. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neonatal Respiratory Distress Syndrome Treatment Market

17.1. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neonatal Respiratory Distress Syndrome Treatment Market

18.1. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neonatal Respiratory Distress Syndrome Treatment Market

19.1. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neonatal Respiratory Distress Syndrome Treatment Market

20.1. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market

21.1. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
21.2. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neonatal Respiratory Distress Syndrome Treatment Market

22.1. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neonatal Respiratory Distress Syndrome Treatment Market

23.1. North America Neonatal Respiratory Distress Syndrome Treatment Market Overview
23.2. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neonatal Respiratory Distress Syndrome Treatment Market

24.1. USA Neonatal Respiratory Distress Syndrome Treatment Market Overview
24.2. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neonatal Respiratory Distress Syndrome Treatment Market

25.1. Canada Neonatal Respiratory Distress Syndrome Treatment Market Overview
25.2. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neonatal Respiratory Distress Syndrome Treatment Market

26.1. South America Neonatal Respiratory Distress Syndrome Treatment Market Overview
26.2. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market

27.1. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neonatal Respiratory Distress Syndrome Treatment Market

28.1. Middle East Neonatal Respiratory Distress Syndrome Treatment Market Overview
28.2. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neonatal Respiratory Distress Syndrome Treatment Market

29.1. Africa Neonatal Respiratory Distress Syndrome Treatment Market Overview
29.2. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape And Company Profiles

30.1. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape
30.2. Neonatal Respiratory Distress Syndrome Treatment Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

31. Neonatal Respiratory Distress Syndrome Treatment Market Other Major And Innovative Companies

31.1. Medline Industries
31.2. Becton Dickinson
31.3. Stryker Corporation
31.4. GE Healthcare
31.5. Koninklijke Philips NV
31.6. ResMed Inc.
31.7. Dragerwerk AG & Co. KGaA
31.8. Chiesi Farmaceutici
31.9. ICU Medical Inc.
31.10. Fisher & Paykel Healthcare
31.11. Vyaire Medical
31.12. Laerdal Medical
31.13. Hamilton Medical
31.14. Inspiration Healthcare
31.15. Ventec Life Systems

32. Global Neonatal Respiratory Distress Syndrome Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Respiratory Distress Syndrome Treatment Market

34. Recent Developments In The Neonatal Respiratory Distress Syndrome Treatment Market

35. Neonatal Respiratory Distress Syndrome Treatment Market High Potential Countries, Segments and Strategies

35.1 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer